GM Hemp Co is here to bring the pain relieving power of our natural CBD products straight to your door step.
CBD history

While decades of cannabis prohibition may lead some to assume that the therapeutic benefits of CBD are a recent discovery, that’s far from the truth.

The first documented use of cannabis-derived medicine dates back to 2737 BC when Chinese Emperor Sheng Nung used a cannabis-infused tea to aid with a variety of ailments including memory, malaria, rheumatism, and gout.

Queen Victoria is believed to have used CBD to alleviate menstrual cramps during her reign, which ended in 1901.

Throughout history, cannabis had served as a valuable therapeutic resource; however, during the rise of modern medicine, it was not recognized by most in the medical community due to a lack of scientific evidence.

It wasn’t until 1839, when Irish physician and medical researcher, William B. O’Shaughnessy, published a study which investigated the plant’s therapeutic effects, that researchers did begin to consider the medical applications of cannabis.

In his study, which was then quite controversial, O’Shaughnessy explored the rudimentary effects of cannabis and thoroughly described its potential medical applications, particularly as an anesthetic.

While the Irish researcher may have not realized it then, he had just opened the door towards the discovery of the compounds that would one day be referred to as cannabinoids.

The Early Discovery of Cannabinoids

Nearly a century after O’Shaughnessy published his study, advancements in research and technology revealed the presence of compounds within the cannabis plant.

The first discovery of an individual cannabinoid was made, when British chemist Robert S. Cahn reported the partial structure of Cannabinol (CBN), which he later identified as fully formed in 1940.

Two years later, American chemist, Roger Adams, made history when he successfully isolated the first cannabinoid, Cannabidiol (CBD). His research is also responsible for the discovery of Tetrahydrocannabinol (THC).

Early Research of Cannabinoid Pharmacology

During the early stages of cannabis research, scientists had limited knowledge of cannabinoid structure and an only partial understanding of the biological composition contained within the plant.

Because of this, early researchers could not accurately determine which compound was causing which effect.

Dr. Raphael Mechoulam made the first breakthrough towards understanding the effects of individual cannabinoids in 1963 when he successfully identified the stereochemistry of CBD.

A year later, Mecholam’s made another breakthrough and discovered the stereochemistry of THC, which revealed the cannabinoids direct relationship to the euphoric effects associated with marijuana use, and disassociated CBD as a mind-altering compound.

As research advanced, a landmark victory occurred, when New Mexico passed the 1978 Controlled Substances Therapeutic Research Act, a bill which legally recognized the medicinal value of cannabis.

The momentum continued during the 1980s as Dr. Mechoulam and his team conducted a study on the potential application of CBD for the treatment of epilepsy as a hypnotic.

In the study, Mechoulam and his team administered daily doses of 300mg of CBD to study a group of 8 subjects. After just four months of treatment, half of the subjects stopped having seizures and the others exhibited a decrease in the frequency of their seizures.

This was a huge breakthrough that had the potential to change the lives of more than 50 million epilepsy sufferers from around the world.

Unfortunately, the discovery was not as publicized any type of breakthrough, due to the stigmas towards cannabis during that time.

The work of Dr. Mechoulam and the other early cannabis pioneers would not go in vain though.

Less than a decade later, interest in the therapeutic applications of cannabinoids revealed the discovery of additional cannabinoids, further understanding of cannabinoid structure, and the amazing breakthrough of our body’s Endocannabinoid System (ECS) — a network of receptors that interact with receptors found in cannabinoids.

As research progressed, it would eventually lead to an explosion of interest across the United States.

Leave a Reply

Your email address will not be published. Required fields are marked *